Showing results (241-250 of 499) with videos related to

Sort By:
Pageof 50
Cellular Microbiology|January 17, 2017
Pathogenic Streptococcus strains employ novel escape strategy to inhibit bacteriostatic effect mediated by mammalian peptidoglycan recognition proteinJing Wang, Youjun Feng, Changjun Wang, et al.
Viruses|March 26, 2022
The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its VariantsJing Pu, Xiaoyang He, Wei Xu, et al.
The Journal of Biological Chemistry|November 25, 2010
In vitro selection and characterization of HIV-1 variants with increased resistance to sifuvirtide, a novel HIV-1 fusion inhibitorZhonghua Liu, Mei Shan, Li Li, et al.
Plos One|March 18, 2011
Susceptibility of HIV-1 subtypes B', CRF07_BC and CRF01_AE that are predominantly circulating in China to HIV-1 entry inhibitorsXiaoling Yu, Lin Yuan, Yang Huang, et al.
Bioinformatics (Oxford, England)|April 1, 2014
CorMut: an R/Bioconductor package for computing correlated mutations based on selection pressureZhenpeng Li, Yang Huang, Yabo Ouyang, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|June 28, 2013
[Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism]Heng Duan, Yuqin Wang, Deshou Song, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2008
Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strainsYuxian He, Jianwei Cheng, Hong Lu, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2014
Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitorsNa Liu, Bingjie Qin, Lian-Qi Sun, et al.
Current Pharmaceutical Design|October 15, 2014
A nanoparticle-encapsulated non-nucleoside reverse-transcriptase inhibitor with enhanced anti-HIV-1 activity and prolonged circulation time in plasmaWen Li, Qian Wang, Yuan Li, et al.
Amino Acids|September 16, 2016
A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41Xifeng Jiang, Qiyan Jia, Lu Lu, et al.
Pageof 50